BiomX Inc. (NYSEAMERICAN:PHGE – Get Free Report) dropped 12.2% on Wednesday . The stock traded as low as $0.50 and last traded at $0.51. Approximately 103,655 shares changed hands during trading, a decline of 7% from the average daily volume of 110,983 shares. The stock had previously closed at $0.58.
BiomX Price Performance
The stock has a market capitalization of $9.90 million, a price-to-earnings ratio of -0.15 and a beta of 1.31.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Further Reading
- Five stocks we like better than BiomX
- What is the FTSE 100 index?
- Tesla Investors Continue to Profit From the Trump Trade
- What Does Downgrade Mean in Investing?
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
